Robert Levande is listed as an executive officer, director, and promoter on 4 SEC Form D filings by 2 issuers between Nov 2014 and Sep 2017: Pulse Biosciences, Inc. (Hayward, CA — other health care — 2014–2017; $50M reported sold to 72 investors) and theMaven, Inc. (New York, NY — other technology — 2017; $23.1M reported sold to 26 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 3 years. Across those companies the filings report $73.1M sold in total.
Listed alongside Brian B. Dow (2 shared filings), Christopher Marlett (2 shared filings), Darrin Uecker (2 shared filings), Maky Zanganeh (2 shared filings), Mitchell Levinson (2 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Robert Levande and found 8 differences: Robert Levande's role changed at Pulse Biosciences, Inc.: director, promoter → director; Robert Levande's role changed at Pulse Biosciences, Inc.: executive officer, director → director, promoter; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.